4.7 Article

Comparison of Seroconversion in Children and Adults With Mild COVID-19

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant

Baisheng Li et al.

Summary: This article reports the first local transmission of the Delta variant in mainland China. Compared to A/B lineage infections during the first wave in China in early 2020, Delta infections had viral loads that were on average about 1000 times greater when they first tested positive, suggesting potentially faster viral replication and greater infectiousness during early infection. The transmission bottleneck size of the Delta variant was generally narrow, with 1-3 virions in most donor-recipient transmission pairs. However, transmission of minor intra-host variants resulted in at least 3 of the 34 substitutions identified in the outbreak, highlighting the contribution of intra-host variants to population-level viral diversity during rapid spread.

NATURE COMMUNICATIONS (2022)

Article Pathology

A Comparison of Five SARS-CoV-2 Molecular Assays With Clinical Correlations

Gary W. Procop et al.

Summary: Comparative assessments of five SARS-CoV-2 molecular assays showed that tests with nucleic acid extraction and reverse transcription polymerase chain reaction were more sensitive, with most false negatives occurring in patients with low viral loads.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Infectious Diseases

Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19

Satoshi Kutsuna et al.

Summary: The study found that male sex, high C-reactive protein levels during the acute phase, and diabetes mellitus were associated with elevated antibody titers in convalescent COVID-19 patients. Antibody titers tended to peak in the first 5 or 6 weeks after symptom onset.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2021)

Article Medicine, General & Internal

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

S. F. Lumley et al.

Summary: In a longitudinal study of seropositive and seronegative health care workers undergoing asymptomatic and symptomatic SARS-CoV-2 testing, the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Immunology

SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response

Mar Masia et al.

Summary: The study found that viral replication determines the magnitude of antibody response to SARS-CoV-2 in COVID-19 patients, which contributes to viral clearance. Some patients are unable to produce antibodies, exhibiting different virological and clinical profiles.

OPEN FORUM INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Humoral signatures of protective and pathological SARS-CoV-2 infection in children

Yannic C. Bartsch et al.

Summary: The study reveals that the development of multisystem inflammatory syndrome in children (MIS-C) is associated with elevated levels of pathogen-specific IgG antibodies, which is different from children infected with SARS-CoV-2 who do not develop MIS-C. Using systems serology, it was found that children have a functional immune response to SARS-CoV-2, while adults may have different immune responses leading to varying disease severity.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children

Melanie R. Neeland et al.

Summary: Children with mild SARS-CoV-2 infection exhibit reduced subsets of circulating monocytes, dendritic cells, and natural killer cells during the acute phase, along with an increase in activated neutrophils. In contrast, infected adults show a reduction in non-classical monocytes. Both children and adults exposed to SARS-CoV-2, even if PCR testing is negative, display increased proportions of low-density neutrophils up to 7 weeks post exposure. This study provides insights into the differences in innate immune responses between children and adults during SARS-CoV-2 infection.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Delayed production of neutralizing antibodies correlates with fatal COVID-19

Carolina Lucas et al.

Summary: Recent studies have shown that COVID-19 mortality is not primarily correlated with antiviral antibody levels, but more with the slower kinetics of antibody production.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues

Fan Yang et al.

Summary: The study found that B cell memory varies for different pathogens, with pediatric blood containing abundant class-switched clones and adult lymphoid tissues having more class-switched clones. Early childhood B cell clonal expansions and cross-reactivity play a significant role in future responses to novel pathogens.

SCIENCE (2021)

Article Multidisciplinary Sciences

Systems serology detects functionally distinct coronavirus antibody features in children and elderly

Kevin J. Selva et al.

Summary: The study reveals that elderly individuals have higher levels of cross-reactive antibodies before the COVID-19 pandemic, while children have fewer exposures to coronaviruses before the emergence of the virus, resulting in less-experienced but stronger humoral immunity. Age-dependent analysis in COVID-19 patients shows elevated class-switched antibodies in the elderly and stronger Fc responses in children.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies

Nicola Cotugno et al.

Summary: This study highlighted the importance of understanding adaptive immunity to SARS-CoV-2 in children, showing that specific humoral responses were associated with faster virus clearance and lower viral load. Frequencies of SARS-CoV-2-specific T cells and B cells correlated with antibody production and neutralizing activity.

CELL REPORTS (2021)

Article Critical Care Medicine

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

Andrew Letizia et al.

Summary: Young adults with SARS-CoV-2 antibodies have about one-fifth the risk of subsequent infection compared to those without antibodies. While antibodies from initial infection offer protection, they do not guarantee effective neutralization or immunity against future infection. These findings could impact mass vaccination strategies.

LANCET RESPIRATORY MEDICINE (2021)

Article Medicine, Research & Experimental

Natural mucosal barriers and COVID-19 in children

Carl A. Pierce et al.

Summary: Children infected with SARS-CoV-2 show a more robust early mucosal immune response compared to adults, which may contribute to favorable clinical outcomes. Higher levels of IFN signaling and other innate pathways were observed in children, along with increased levels of certain cytokines in nasal fluid, suggesting a more protective immune response in children against severe COVID-19.

JCI INSIGHT (2021)

Article Medicine, General & Internal

Association of Age With SARS-CoV-2 Antibody Response

He S. Yang et al.

Summary: The study found that there are distinct viral-specific antibody response profiles in different age groups with children showing higher levels of antibody response. Therefore, age-targeted strategies for disease screening, management, and vaccine development may be necessary.

JAMA NETWORK OPEN (2021)

Article Infectious Diseases

Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study

Francesca Rovida et al.

Summary: The study evaluated the protective effect of SARS-CoV-2 anti-S1 and anti-S2 IgG antibody positivity induced by natural infection against SARS-CoV-2 infection. The results showed that immunity from natural infection can reduce the risk of secondary infection and alleviate symptoms.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Editorial Material Biochemistry & Molecular Biology

A correlate of protection for SARS-CoV-2 vaccines is urgently needed

Florian Krammer

NATURE MEDICINE (2021)

Article Pediatrics

Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers

Francesco Bonfante et al.

Summary: In a family cluster, children with mild or asymptomatic infections of severe acute respiratory syndrome coronavirus 2 developed higher levels of neutralizing antibodies compared to older siblings and adults.

PEDIATRICS (2021)

Article Multidisciplinary Sciences

Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection

Serena Marchi et al.

Summary: The study showed that hospitalized COVID-19 patients produce a strong antibody response to SARS-CoV-2 with high correlation between different viral antigens and antibody classes. The antibody peak is reached around 3 weeks from hospital admission followed by a sharp decrease. There was no difference in antibody levels between patients who recovered or had a fatal outcome, and few asymptomatic subjects developed detectable levels of antibodies.

PLOS ONE (2021)

Article Immunology

Evidence for antibody as a protective correlate for COVID-19 vaccines

Kristen A. Earle et al.

Summary: The study found a strong correlation between antibody titers and efficacy when assessing different COVID-19 vaccines, supporting the use of post-immunization antibody titers as the basis for establishing a correlate of protection for COVID-19 vaccines.

VACCINE (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection

Carolyn A. Cohen et al.

Summary: This study shows that infected children have lower CD4(+) and CD8(+) T cell responses to SARS-CoV-2 proteins compared to infected adults. Children also have reduced CD4(+) T cell effector memory but comparable T cell polyfunctionality.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery

Chengqian Feng et al.

Summary: The study found that SARS-CoV-2 specific immune response can persist to some extent up to 1 year after recovery from COVID-19, with serum neutralizing capacity decreasing but remaining stable. Viral-specific cellular immune protection persists between 6 months and 12 months after recovery.

NATURE COMMUNICATIONS (2021)

Editorial Material Medicine, General & Internal

Covid-19: Cases in children rise sharply in US as doctors call for vaccine approval

Janice Hopkins Tanne

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Oncology

Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan

Shu Yazaki et al.

Summary: This study evaluated the serum SARS-CoV-2 antibody status in cancer patients and healthcare workers in Japan during the COVID-19 pandemic. The seroprevalence did not differ significantly between the two groups, but it was found that cancer comorbidity and treatment with chemotherapy and immune checkpoint inhibitors may impact the immune response to SARS-CoV-2.

JAMA ONCOLOGY (2021)

Article Medicine, Research & Experimental

Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents

Carolina Garrido et al.

Summary: The study found that children and adolescents with mild or asymptomatic SARS-CoV-2 infection generate strong and durable humoral immune responses, which may help prevent reinfection.

JCI INSIGHT (2021)

Article Immunology

Predictors of Nonseroconversion after SARS-CoV-2 Infection

Weimin Liu et al.

Summary: Not all individuals recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. Factors associated with non-seroconversion include younger age and higher reverse transcription PCR cycle threshold values, with viral loads in the nasopharynx identified as a major correlate of the systemic antibody response.

EMERGING INFECTIOUS DISEASES (2021)

Letter Immunology

Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia

Zheng Quan Toh et al.

Summary: The duration of humoral immune response in children infected with COVID-19 is still unknown, but specific IgG was detected 6 months after infection in asymptomatic or mildly symptomatic children. These findings will help inform vaccination strategies and other prevention measures.

EMERGING INFECTIOUS DISEASES (2021)

Article Pediatrics

Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study

Thomas Waterfield et al.

Summary: This study found that children had similar antibody responses to SARS-CoV-2 regardless of age, with fatigue, gastrointestinal symptoms, and changes in sense of smell or taste being the symptoms most strongly associated with SARS-CoV-2 antibody positivity.

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Article Medicine, Research & Experimental

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

Bezawit A. Woldemeskel et al.

Summary: Recent studies have shown that T cells can cross-recognize spike proteins of SARS-CoV-2 and common cold coronaviruses. Vaccination with SARS-CoV-2 mRNA vaccines results in broad T cell responses to the virus's spike protein, including potential recognition of variant spike proteins. Additionally, post-vaccination, there is an observed increase in CD4(+) T cell responses to certain common cold coronaviruses.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Immunology

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients

Frauke Muecksch et al.

Summary: Understanding the longitudinal trajectory of SARS-CoV-2 antibodies is crucial for diagnosis and immunity prediction. Different serological assays have varying suitability for surveillance and prediction of neutralization potency, with S-based assays better predicting neutralization levels over time.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Immunology

Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

Stuart P. Weisberg et al.

Summary: This study found distinct antibody responses in children and adults after SARS-CoV-2 infection. Adult COVID-19 cohorts showed a broader range of antibody responses, while children predominantly generated antibodies specific for the S protein and had reduced neutralizing activity compared to adults.

NATURE IMMUNOLOGY (2021)

Article Immunology

Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features

Louise C. Rowntree et al.

Summary: The study utilized various serology testing methods to conduct a comprehensive analysis of the SARS-CoV-2 virus, finding that commercial ELISA results were consistent with in-house ELISA results, rapid sVNT inhibition frequency strongly correlated with spike-specific IgG and IgA titres, and multiplex analyses revealed the strongest correlations between spike and RBD-specific antibodies.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat et al.

NATURE MEDICINE (2020)

Editorial Material Pediatrics

The immune system of children: the key to understanding SARS-CoV-2 susceptibility?

Rita Carsetti et al.

LANCET CHILD & ADOLESCENT HEALTH (2020)

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Article Virology

SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons

Nele Wellinghausen et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Article Medicine, General & Internal

Humoral Immune Response to SARS-CoV-2 in Iceland

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cell Biology

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

Carl A. Pierce et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Review Multidisciplinary Sciences

Antibody response to SARS-CoV-2 infection in humans: A systematic review

Nathan Post et al.

PLOS ONE (2020)

Article Immunology

B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients

Victor A. Sosa-Hernandez et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg et al.

SCIENCE (2020)

Article Medicine, Research & Experimental

Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals

Fang Gong et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19

Shidan Tosif et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Xiangyu Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)